EXCLUSIVE MEDICINES BRISTOL, SA

This tender concerns the procurement of exclusive medicines supplied by Bristol Myers Squibb (Bristol, SA). Bristol Myers Squibb is a major global biopharmaceutical company known for developing innovative treatments, particularly in areas such as oncology, immunology, cardiovascular disease, and neuroscience. The term "exclusive medicines" suggests that these are specific pharmaceutical products for which Bristol Myers Squibb holds exclusive rights, possibly patented drugs or specialized therapies. The tender is likely issued by a healthcare provider, hospital, or national health system seeking to acquire these specific medications. The procurement may be for a particular drug or a range of drugs from the Bristol Myers Squibb portfolio. Bidders, likely distributors or the manufacturer itself, will need to demonstrate their authorization to supply these exclusive products and adhere to strict pharmaceutical supply chain requirements, including cold chain management if applicable. The tender will specify the exact medications, quantities, delivery terms, and quality standards required.

This is a supplies contract in the health and medical services, trade and industry and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 136,477.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.